Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
3-year results show that patients who underwent low-risk aortic valve replacement continue to report lower rates of all-cause mortality and stroke with TAVI compared to surgery
Read Full NewsA groundbreaking study reveals that combining ixekizumab and tirzepatide significantly improves outcomes for adults with psoriatic arthritis and obesity.
Coya Therapeutics reveals promising results for COYA 302, a potential treatment for frontotemporal dementia, showing cognitive stability and Treg enhancement.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on the International Stroke Conference (ISC)!
Here's some of what is coming soon to NeurologyLive® this week.
FDA Clears LEADOPTIK's LIA System for Higher-Accuracy Lung Biopsy
1.
Adding Isatuximab to Standard Backbone Prolongs PFS in Myeloma
2.
Radionuclide-Containing Combo Slows Metastatic Prostate Cancer, Improves Survival
3.
Alone for 500 Days, but Never Lonely: The Introvert's Dream.
4.
How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace
5.
Short-course radiation matches standard therapy for endometrial cancer
1.
Mastering Modern Oncology: Accreditation, Education, and Research Trends for 2025
2.
The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
An Overview Of Daunorubicin: What Is It Used For And How Does It Work?
5.
Immunotherapy Breakthroughs: Transforming Cancer Care Across All Oncology Fields
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
2.
Updates on the First Line Management of ALK+ NSCLC
3.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
5.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge